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Abstract 
The term proteoglycan encompasses a heterogeneous group of heavily 
modified metazoan glycoproteins that are involved in fundamental biologi-
cal processes. They are essential for embryonic development and play im-
portant roles in tissue organization and cell haemostasis. Proteoglycans are 
also linked to pathogenesis and modulate key processes related to microbi-
al infection, cancer behaviour and cardiovascular dysfunction. To under-
stand their impact on human health and disease, thorough studies of their 
structure-and-function relationships are required. However, this has been 
hampered by technical difficulties mainly related to the structural complex-
ity of their modifying glycosaminoglycan (GAG) chains. 
  In this thesis, we developed protocols for the purification and struc-
tural characterization of chondroitin sulfate (CS) and heparan sulfate (HS) 
proteoglycans from complex samples. Our approaches were enclosed with-
in a glycoproteomics framework allowing for the simultaneous identifica-
tion of the core-proteins and the glycan attachment sites. Additionally, they 
facilitated the characterization of the proteoglycan linkage region. Our 
workflows entailed multiple enzymatic degradation steps, chromatographic 
separation and high-resolution tandem mass spectrometry. Finally, we de-
veloped SweetNET, a bioinformatics platform to cope with the large 
amounts of data generated from these high-throughput experiments.   
  In addition to the limited number of known mammalian proteogly-
cans (less than 50), we identified 21 novel human core proteins modified 
with CS chains. We found that several pro-hormones carry CS-modifica-
tions, defining them as a novel class of proteoglycans. We also identified 
novel glycan variations of the proteoglycan linkage region, close to the 
peptide attachment site, which included fucosylation and sialylation. The 
examination of the small CS proteoglycan bikunin across different human 
body fluids revealed an unforeseen heterogeneity of its linkage region, es-
pecially in urinary samples. In addition, we could determine the exact ma-
cromolecular architecture of the bikunin CS-chain within the inter-alpha 
trypsin inhibitor complex in serum and cerebrospinal fluid. Finally, we 
identified placental-type GAGs in induced pluripotent stem cells using a 
recombinant malaria protein probe. These GAGs displayed a stage-specific 
dependence and were associated with a heterogeneous group of core-
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proteins. The extent and biological implications of these findings for basic 
stem cell biology need further clarification. 
  Taken together, we have established preparative and analytical pro-
tocols as well as bioinformatics tools for the structural characterization of 
native proteoglycans in complex samples. This led us to identify novel 
human proteoglycans as well as novel glycosaminoglycan modifications. 
Finally, we found that the proteoglycan landscape of pluripotent stem cells 
changes upon differentiation and can be specifically targeted using a 
unique protein probe. 
Keywords 
Proteoglycans, glycosaminoglycans, mass spectrometry, VAR2CSA, iPS 
cells, bikunin, inter-alpha trypsin inhibitor, bioinformatics, glycopeptides, 
pro-hormones 
 Sammanfattning på svenska 
Proteoglykaner omfattar en heterogen grupp av komplext modifierade gly-
koproteiner vilka är inblandade i grundläggande biologiska processer. De 
spelar en viktig roll under embryonal utveckling och är avgörande för upp-
rätthållande av flera basala cellfunktioner. Proteoglykaner är kliniskt in-
tressanta för flera olika sjukdomar genom att de reglerar viktiga meka-
nismer relaterade till infektion, cancer och fettmetabolism. En detaljerad 
kartläggning av deras struktur-och-funktion samband är nödvändig för att 
bättre kunna utnyttja deras diagnostiska och terapeutiska potential. Proteo-
glykaner är modifierade med olika kolhydrater i långa och heterogena s.k. 
glykosaminoglykan-kedjor vilka alltid utgjort en svår analytisk utmaning 
vad avser deras strukturella karakterisering. 
  I denna avhandling har vi utvecklat preparativa och analytiska pro-
tokoll för rening och strukturkarakterisering av kondroitinsulfat (CS) och 
heparansulfat (HS) innehållande proteoglykaner från komplexa prover. 
Våra glykoproteomik-liknande metoder möjliggör identifiering av bärar-
proteinet, lokalisering av den exakta positionen av kolhydratkedjan i prote-
insekvensen samt strukturell karakterisering av kolhydratkedjans innersta 
del, den s.k. länkregionen. Dessa metoder innefattar flera enzymatiska 
nedbrytningssteg, kromatografiska separationer och högupplösande tandem 
masspektrometri (MS/MS). Slutligen utvecklade vi programvaran Sweet-
NET som en helt ny och generell bioinformatisk plattform för effektiv han-
tering och tolkning av tiotusentals masspektra erhållna från MS/MS-analys 
av olika glykoproteiner. 
  Utöver det begränsade antalet kända däggdjurs proteoglykaner (<50 
st) lyckades vi identifiera 21 st nya humana proteiner modifierade med CS-
kedjor. Vi fann att flera pro-hormoner kan bära CS-modifieringar vilket 
gör dem till en ny klass av proteoglykaner. Vi identifierade också nya mo-
difikationer i länkregionen av proteoglykanerna, bland annat fukosylering 
och sialylering. Dessutom kunde vi bestämma den exakta makromole-
kylära arkitekturen av inter-alfa-trypsin-inhibitor komplexet i serum och i 
cerebrospinalvätska. Slutligen identifierade vi uttrycket av placenta-typ 
GAG kedjor hos inducerade pluripotenta stamceller med hjälp av ett re-
kombinant malariaprotein, VAR2CSA. Detta uttryck var beroende av 
stamcellernas differentieringsgrad och kunde förknippas med en heterogen 
grupp av både kända och okända proteoglykaner. 
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  Sammantaget har vi etablerat preparativa och analytiska protokoll 
samt bioinformatiska verktyg för strukturell karakterisering av nativa pro-
teoglykaner i komplexa biologiska prover. Detta har lett fram till att vi 
kunnat identifiera helt nya humana proteoglykaner och nya modifikationer 
av deras glykosaminoglykan kedjor. Slutligen fann vi även att proteogly-
kaner på pluripotenta stamceller förändras vid differentiering såväl vad 
avser GAG-kedjorna som deras bärarproteiner.
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 Abbreviations 
B3GalT6 Beta-1,3-galactosyltransferase 6 
B4GalT7 Beta-1,4-galactosyltransferase 7 
BMP1 Bone morphogenetic protein 1 
CHGA Chromogranin A 
ChondABC Chondroitinase ABC 
ChSy-1, -2,-3 Chondroitin synthase-1, -2, -3 
CID Collisional induced dissociation 
CS Chondroitin sulfate 
CSA Chondroitin sulfate A 
CSGalNAcT-1 Chondroitin sulfate N-acetylgalactosaminyltransferase 1 
CSGalNAcT-2 Chondroitin sulfate N-acetylgalactosaminyltransferase 2 
DC Direct current 
DS Dermatan sulfate 
DS-epi1 Dermatan sulfate epimerase 1 
DS-epi2 Dermatan sulfate epimerase 2 
ECM Extracellular matrix 
ESC Embryonic stem cell 
ESI Electrospray ionization 
EXT-1 Exostosin-1 
EXT-2 Exostosin-2 
EXTL3 Exostosin-like 3 
FGF-2 Fibroblast growth factor 2 
Fuc Fucose 
GAG Glycosaminoglycans 
Gal Galactose 
GalNAc N-acetylgalactosamine 
GlcA Glucuronic acid 
GlcNAc N-acetylglucosamine 
HA Hyaluronic acid 
HCD Higher-energy collisional dissociation  
HexA Hexuronic acid 
 ABBREVI ATI ONS    15
HexNAc N-acetylhexosamine 
HS Heparan sulfate 
IdoA Iduronic acid 
IE Infected erythrocytes 
iPS cells Induced pluripotent stem cells 
IαI Inter-alpha-trypsin inhibitor 
KS Keratan sulfate 
LC Liquid chromatography 
MALDI Matrix-assisted laser desorption/ionization 
MS Mass spectrometry 
MS/MS Tandem mass spectrometry 
NDST1 Heparan sulfate N-deacetylase/N-sulfotransferase 1 
NeuAc N-acetylneuraminic acid 
OA Osteoarthritis 
PNA Peanut agglutinin 
PSM Peptide-spectrum match 
RF Radio frequency 
SAX Strong anion exchange 
SRGN Serglycin 
UDP Uridine diphosphate 
UEA-1 Ulex europaeus agglutinin I 
UTI Urinary trypsin inhibitor 
VEGF Vascular endothelial growth factor 
XT-1 Xylosyltransferase 1 
XT-2 Xylosyltransferase 2 
Xyl Xylose 
ΔHexA 4,5-unsaturated hexuronic acid 
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1. Introduction 
1.1 Finding the coordinates of the thesis  
According to the Oxford English Dictionary, glycobiology is defined as the 
branch of science concerned with the role of sugars in biological systems. A 
more rigorous definition would probably include:  
“the study of the structure, biosynthesis, biology and evolution of saccha-
rides (sugar chains or glycans) that are widely distributed in nature, and 
the proteins that recognize them” (Varki & Sharon, 2009). 
 At a first glance, these notions may suggest that glycobiology qualifies as a 
subdiscipline within the much broader field of biochemical research. However, 
in a strict historiographical sense, the demarcation between these two disciplines 
is less clear than what it is usually realized. In fact, it could be equally argued 
that the genesis of modern biochemistry was profoundly shaped by fundamental 
developments in early carbohydrate research.  
 Louis Pasteur counts among the European pioneers that embarked into the 
systematic study of alcoholic fermentation during the 19th century (Fig 1). After 
several years of experimental research on yeast cells, Pasteur finally arrived to 
the conclusion that a “vital force” called “ferment” was responsible for the con-
version of sugars into alcohols (Pasteur, 1860). This notion was in line with 
popular ideas about the “vitalistic” nature of the world and found therefore an 
easy way into the heart of most European scientific circles. However, soon after 
that, a German chemist by the name of Justus von Liebig started one of the most 
interesting controversies in the history of modern chemistry: the Liebig-Pasteur 
dispute (Hein, 1961). This dispute had many angles but it could be summarized 
as Pasteur holding that fermentation was a biological process (exclusively de-
pending on living organisms) while Liebig claimed that it was a mechanical pro-
cess (caused by vibrations from the decomposition of organic matter). To make 
things even more complicated, both chemists had different experimental ap-
proaches and different ideas about where fermentation took place in an organ-
ism. Later on, and building onto these concepts, Eduard Buchner demonstrated 
that living cells were not an absolute pre-requisite for the chemical conversion. 
In a series of seminal reports published in 1897, Buchner cleverly undermined 
Pasteur’s assumptions by proving that cell-free yeast extracts were equally suffi-
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cient to induce sugar fermentation (Buchner, 1897). However, Buchner’s results 
also pointed to the existence of a substance, similar to the Pasteurian “ferment” 
that was required for the reaction to take place. For the modern reader, the far-
reaching consequences of these specialized controversies may be difficult to 
grasp but from a philosophical point of view, the impact of Buchner’s research 
should not be underestimated. Buchner’s results provided some of the first ex-
perimental counter-evidences to vitalistic hypotheses claiming that living organ-
ism were fundamentally different to non-living entities. The mysterious 
substances required for fermentation were eventually denoted enzymes but their 
biochemical nature remained for long unknown.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Louis Pasteur was a scientific pioneer in the study of fermentation, in which 
yeast cells break down sugars into ethanol and carbon dioxide. “Louis Pasteur in his 
laboratory”, reproduction of a painting from 1885 by the Finnish artist Albert Gustaf 
Aristides Edelfelt. 
 
  Equally enigmatic was the nature of the interaction between enzymes and 
their target substances. Reflecting upon the fact that yeasts fermented the D- but 
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not the L-form of the monosaccharides mannose, glucose and galactose, Emil 
Fischer hypothesized that structural determinants are required for the enzymes to 
act on their substrates:  
“To use a metaphor, I would like to say that enzyme and glucoside have to 
fit together like lock and key in order to exert a chemical effect on each 
other” (E. Fischer, 1894).  
Fischer’s image of lock and key is a beautiful scientific metaphor that has paved 
the way for our current understanding of basic enzymology. These few examples 
among many others, serve to illustrate that the intellectual genealogies of bio-
chemistry and glycobiology are indeed deeply intertwined.  
 The presence of cell surface glycosylation is a common denominator in 
virtually all living cells (Varki, 2011). In a sense, it can be compared to the uni-
versality of having a genetic code or to the fact that biological membranes are 
build-up of lipids. Most of the focus on glycans in biological systems has tradi-
tionally been put on metabolism. However, the accumulated data to this day 
links glycosylation to every fundamental cellular process. Glycans may appear in 
multiple cellular locations, and not only as free sugars but more often as gly-
coconjugates (i.e. covalently linked to other biomolecules as glycoproteins, gly-
colipids etc.), which makes them versatile tools for mediating, regulating and 
fine-tuning cellular functions. As expected, their biological roles may then span 
from subtle to essential for the development and survival of living organisms. In 
addition to that, glycosylation is by no way devoid of medical interest. Disturb-
ances in glycan biosynthesis and catabolism are the main causatives of a plethora 
of pathophysiological processes (Freeze et al., 2014; Hennet & Cabalzar, 2015). 
Glycans constitute the first cellular barrier encountered by microbial pathogens 
during infection and their potential as therapeutic targets has been widely 
acknowledged (Fuster & Esko, 2005). Having said that, how does it come that 
the study of such important biomolecules has become the subject of a surprising-
ly small scientific community? What are the reasons for singling out glycobiolo-
gy as an independent discipline? (There is not such a thing as proteo-biology or 
lipido-biology). The answer to those questions is not straightforward but one 
important clue lies in the nature of the subject itself (Lindahl, 2014; Roseman, 
2001). Glycans (and glycoconjugates) are without exaggeration the most diverse, 
structurally complex, and analytically challenging biomolecules of the entire 
biological realm. 
 Glycans are secondary gene products and their biosynthesis is a well-
orchestrated process. In general, glycan biosynthesis is considered to take place 
in a non-template driven fashion, which is dependent on the interplay of multiple 
glycosyltransferases, glycosidases, and other glycan modifying enzymes. It also 
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requires the presence of activated sugar nucleotides, transporters and chaperones 
located along the secretory pathway in the endoplasmic reticulum and Golgi 
compartments. Compared to other biomolecules such as proteins or nucleic ac-
ids, glycans are composed of a larger number of building blocks called mono-
saccharides that can be connected to each other at different positions and with 
different linkage configurations. Glycans might be linear or branched and addi-
tional chemical substitutions such as acetylation, sulfation or phosphorylation 
are common, which exponentially increases the diversity of glycan structures in 
nature. The presence of glycoconjugates adds new levels of complexity and 
functionality. In many cases, the glycan moiety accounts for a significant part of 
the total molecular weight of a glycoconjugate and can play a major role in its 
biosynthesis, processing, location, trafficking and context-dependent function. 
Finally, most glycans enjoy a tremendous flexibility in aqueous solution due to 
their intrinsic structural properties. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 2. The proteoglycans are complex glycoconjugates composed of a core protein 
and one or more acidic glycosaminoglycan chains. The large sizes and distinct chemical 
nature of the glycan chains have a great impact on the overall physicochemical proper-
ties of the proteoglycans. In this picture, the crystal structure of the small human proteo-
glycan bikunin (PDB: 1BIK) has been depicted in orange using a surface layout. A twenty 
amino acid long stretch containing the GAG-attachment at the very N-terminus of the 
protein is colored in pink. A seventeen monosaccharide long CS chain (sphere represen-
tation) was modelled and attached to the core-protein. Picture was created using PyMol. 
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 This thesis is devoted to the study of a special class of glycoconjugates, 
the proteoglycans (Fig 2), which are the carriers of the largest and most structur-
ally complex of all glycan modifications, the glycosaminoglycans. In spite of 
their ubiquitous presence in every cell membrane and in the extracellular matrix 
(ECM), advances towards deciphering the relationships between the structure 
and function of the native proteoglycans have been exceptionally slow-paced. In 
fact, obtaining the complete structure of an intact heparan sulfate proteoglycan, 
still an unrealized dream, including all of its substitutions, the glycosaminogly-
can attachment site on the protein and the glycan domain architecture, is possibly 
one of the most difficult structural challenges in modern biochemistry. 
1.2 “The reluctant mucopolysaccharides”      
The nature of the amorphous “ground substance” that surrounds the cells in con-
nective tissues received great attention during the 19th century. Most of the ear-
lier descriptions of this substance were restricted to anatomic or microscopic 
examinations. Nevertheless, histologists became quickly acquainted with the 
anionic character of its major chemical components, a property that was exploit-
ed to develop several staining procedures for microscopic visualization. It was 
not until the development of novel extraction procedures when the presence of a 
distinct family of related acidic polysaccharides, now denoted glycosaminogly-
cans, was finally demonstrated in cartilage (G. a. B. Fischer, C., 1861). The bio-
chemical analysis of these polysaccharides, at that time known as “mucopoly-
saccharides”, constituted the main target for several pioneering studies that laid 
the basis for our understanding of the composition, structural diversity and phys-
icochemical properties of the glycosaminoglycans. In this context, the unique 
work of Karl Meyer and his co-workers stands out as an extraordinary scientific 
accomplishment entailing, among other things, the discovery of hyaluronic acid 
(Palmer, 1934 ), dermatan sulfate (K. Meyer, and Chaffee, E., 1941), keratan 
sulfate (K. Meyer, Linker, A., Davidson, E. A., and Weissmann, B, 1953) and 
the initial differentiation between multiple classes of chondroitin sulfate (K. 
Meyer, Davidson, E. A., Linker, A., and Hoffman, P, 1956). A different line of 
research with a primary focus on blood coagulation led to the isolation of hepa-
rin (McLean, 1916), and eventually, to the discovery of another important class 
of glycosaminoglycans, the heparan sulfate (Jorpes, 1948).  
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1.2.1 Structural diversity of the glycosaminoglycans 
The term glycosaminoglycan (GAGs) denotes a group of linear polysaccharides 
whose repetitive building blocks consist of an amino sugar and an uronic acid (or 
a galactose). GAGs are usually divided into four major groups: chondroitin 
/dermatan sulfate (CS/DS), heparan sulfate (HS), hyaluronic acid (HA) and kera-
tan sulfate (KS); based on their monosaccharide compositions and structures 
(Fig 3). Hitherto, GAG expression has only been demonstrated in metazoan or-
ganisms. HA has a more recent evolutionary history and appears restricted to 
vertebrates. Some species-specific patterns in the fine structure of GAGs have 
also been described. For example, the CS chains synthesized by invertebrates 
such as Drosophila melanogaster or Caenorhabditis elegans are mostly devoid 
of sulfate substitutions, in contrast to the vast majority of CS chains produced by 
vertebrate organisms. However, very recent findings have started challenging 
these widely-held notions (Dierker et al., 2016; Izumikawa et al., 2016).   
 
 
Figure 3. Native glycosaminoglycans display a broad structural diversity. They are tradi-
tionally divided into 4 major groups. Chondroitin/ dermatan sulfate, heparan sulfate, and 
keratan sulfate appear glycosidically bound to a polypeptide chain in the form of a prote-
oglycan. Hyaluronic acid is secreted as a free glycan. Glycosaminoglycans are present in 
different locations such as the cell membrane, the extracellular matrix, and inside secre-
tory vesicles. 
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  The main repetitive disaccharide unit of CS is (GalNAcβ4GlcAβ3) while 
HS chains are predominantly built of (GlcNAcα4GlcAβ4). Enzymatical elonga-
tion of these basic units can generate very large structures and GAG chains of 
20-50 kDa are common. A high degree of further variation is achieved by chem-
ical substitutions with sulfates (and sometimes phosphate) groups attached to 
different monosaccharide residues and at different positions. A certain level of 
epimerization of glucuronic acid (GlcA) into iduronic acid (IdoA) is also present 
in CS giving rise to the related polysaccharide DS. IdoA is also present in HS 
structures within modular distributions of sulfated and epimerized domains. Both 
CS/DS and HS are long and polydisperse polysaccharides. The carboxylic 
groups of the uronic acids and the sulfate substituents confer them with a high 
density of negative charges that helps to shape their acidic nature. During bio-
synthesis, both CS/DS and HS become glycosidically linked to a polypeptide 
chain via a common tetrasaccharide structure. A core protein carrying a GAG 
chain is thus, per definition, a proteoglycan. Due to the large sizes of CS/DS and 
HS chains, the properties of the GAGs tend to dominate the physicochemical 
properties of the proteoglycans. On the other hand, the relevance of the core-
proteins for particular functions cannot be dismissed and is often context-
dependent. Finally, heparin is a subtype of HS that is only produced by connec-
tive-tissue-type mast cells on a specific proteoglycan called serglycin. Compared 
with HS, Heparin chains undergo more extensive epimerization and sulfation, 
including rare sulfation events that are essential for its well-known anticoagulant 
activity (Lever & Page, 2002). 
  The disaccharide composition of HA (GlcNAcβ4GlcAβ3) is similar but 
not identical to CS/DS and HS. HA is devoid of further substitutions such as 
sulfate groups and its biosynthesis does not occur in the secretory pathway. HA 
chains are directly synthetized by a group of integral membrane proteins called 
hyaluronan synthases and extruded via ABC transporters through the cell mem-
brane into the extracellular space. The HA chains appear as free glycans or cova-
lently linked to the heavy chains of the inter-alpha trypsin inhibitor (Chen et al., 
1996).  
  KS constitutes a distinct subclass of GAGs composed of sulfated poly-N-
acetyllactosamine (GlcNAcβ3Galβ4) chains, which are in principle identical to 
those found in other common glycoproteins. These GAG chains are also distin-
guished by being synthetized onto N-glycan core structures (KS-I) or O-glycan 
core 2 structures (KS-II). Keratan sulfate can be further decorated with fucose 
and sialic acids and both the GlcNAc and the Gal residues may serve as targets 
for sulfate substitutions.  
  The large diversity among GAG structures, the presence of different GAG 
types on the same carrier protein (hybrid proteoglycans) and the serendipitous 
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history of their discovery in different labs and at different time points, has large-
ly contributed to the difficulties in developing a standardized system for GAG 
(and proteoglycan) nomenclature and classification. In fact, there is recent exper-
imental evidence for proteins carrying GAG-like polysaccharides but their clas-
sification as proteoglycans is disputable, despite showing striking similarities 
regarding saccharide compositions and structure (Inamori et al., 2016; Yoshida-
Moriguchi & Campbell, 2015). On the other hand, the structural and biosynthetic 
reasons for certain proteins to acquire proteoglycan status are not always clear 
and the demarcation between a glycoprotein and a proteoglycan can sometimes 
become confounding and rather artificial. More importantly, what may appear as 
a theoretical issue has been paralleled by the establishment of a niche within 
glycobiology research exclusively dedicated to the study of GAGs and proteo-
glycans, singling them out from the other glycoproteins. The justification for this 
development deserves historical, structural, and methodological considerations. 
For example, the discovery and structure determination of the major GAG clas-
ses were rapidly accomplished during the first decades of the 20th century but it 
was not until 1958 when their proteinaceous nature was fully realized (Muir, 
1958). That means that a great part of the major methodological and theoretical 
challenges of the GAG field were already conceptualized (but of course not 
completely resolved) by the time when their protein counterparts were finally 
discovered. One of the main points of this thesis is that the transfer of knowledge 
and technical experience from basic glycoprotein research, such as the develop-
ment of glycoproteomics technologies, can generate new insights into GAG and 
proteoglycan structure and function. 
1.2.2 “The missing link” 
The structural characterization of GAGs was accelerated by the development of 
isolation and precipitation methods for their extraction from different tissues. 
Extensive proteolytic digestion was a common step during early GAG extraction 
procedures. The invariable presence of amino acids in these preparations led 
eventually to the hypothesis that GAG chains might be tightly associated with a 
protein component. The first report of such a covalent carbohydrate-protein link 
was based on the finding that serine was exceptionally enriched in CS prepara-
tions from hyaline cartilage after proteolytic digestion (Muir, 1958). Other ami-
no acids were also overrepresented, particularly glutamic acid, proline and 
glycine. The well-known alkali lability of GAG chains added to these observa-
tions by specifically implicating the hydroxyl group of serine as the linking 
group. In a number of elegant studies, Lindahl and Rodén finally solved the 
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complete structure of the linkage region in 1966 and showed that both CS/DS 
and HS proteoglycans share the same tetrasaccharide precursor 
(GlcAβ3Galβ3Galβ4Xylβ1-O-) onto which the GAG chains are further extended 
(Helting & Roden, 1968; Lindahl, 1966, 1968; Lindahl & Roden, 1966). The 
linking monosaccharide turned out to be an aldopentose (five-carbon sugar) 
called xylose. Xylose is widely found across the plant kingdom where it consti-
tutes the main component of the xylan group of hemicelluloses that build up the 
plant cell walls. Otherwise, xylose is a rare monosaccharide in vertebrate glycans 
although some notable exceptions have been described (Haltom & Jafar-Nejad, 
2015). 
1.2.3 The CS/DS and HS linkage region 
The biosynthesis of CS/DS and HS chains takes place in the secretory pathway 
starting with the stepwise assembly of the linkage region. This tetrasaccharide is 
synthetized by the sequential addition of individual monosaccharides rather than 
being transferred “en bloc” as a precursor oligosaccharide. The xylose unit is 
always attached to the hydroxyl group of specific serine residues through a beta 
glycosidic linkage. Similar to other biological glycosylation reactions, the trans-
fer of the linking xylose to the polypeptide requires the presence of a donor sug-
ar nucleotide (UDP-xylose). The first reports of xylose transfer to endogenous 
protein acceptors dates back to the mid-1960s making the peptide- O-
xylosyltransferase one of the first glycosyltransferases to be described (Wilson, 
2004). In vertebrates, two active xylosyltransferase isoforms have been reported 
so far (XT-1 and XT-2). In addition to their slightly different tissue distributions, 
the analysis of their enzyme activities has revealed that both enzymes can trans-
fer xylose to similar peptide acceptors but with different efficiency (Roch et al., 
2010). 
  Given that transfer of xylose is a rate-limiting step in the biosynthesis of 
GAGs, the amino acid preferences of the xylosyltransferases have deserved con-
siderable attention. Despite some early discrepant results pointing to the possi-
bility of threonines becoming xylosylated (Mann et al., 1990), most of the 
accumulated data in vitro and in vivo, indicates that serine residues are the true 
targets for the XT-1 and XT-2 activities. Confirming this notion, the presence of 
endogenous proteoglycans carrying GAG chains at threonine residues has so far 
not been described. In addition, a consensus sequence for GAG attachment has 
been formulated (Brinkmann et al., 1997; Esko & Zhang, 1996; L. J. Zhang et 
al., 1995). GAGs are usually found attached to a Ser-Gly dipeptide flanked by a 
cluster of acidic amino acid residues. The assembly of HS chains in particular, 
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occurs preferentially in region with repetitive Ser-Gly sequences (L. J. Zhang et 
al., 1995). This may indicate that, in certain cases, the xylosyltransferases can act 
in a processive fashion. Interestingly, this “sequon” has been confirmed in later 
studies but a note of caution is pertinent. The primary structure of the acceptor 
does not seem to be the only determinant because the protein conformation has 
also an impact on the efficiency of transfer. The well-recognized existence of 
“part-time” proteoglycans raises additional problems given that the mere pres-
ence of a GAG sequon does not necessarily imply that the site will always be 
glycosylated. Last but not the least, compared to other classes of protein glyco-
sylation, the number of known naturally occurring GAG attachments sites is 
remarkably scarce. Novel methodologies, including the strategies developed in 
this thesis, are expected to increase our knowledge of the true endogenous tar-
gets for the xylosyltransferases and thereby, of their amino acid preferences. 
  After the transfer of the xylose moiety, the assembly of the linkage region 
is completed by the addition of two Gal and one GlcA. The transfer of the Gal 
moieties is catalysed by two independent galactosyltransferases: B4GALT7 
(GalT-I) and B3GALT6 (GalT-II). In turn, the GlcA is transferred by the action 
of B3GAT3 which is not involved in the extension of the repetitive disaccharide 
units of the CS or HS backbone and it is therefore classified as having GlcAT-I 
activity. The attachment of the fifth monosaccharide is a key checkpoint that 
determines if CS (addition of GalNAcβ4) or HS (addition of GlcNAcα4) will be 
synthesized. The presence of a specific set of dedicated enzymes and a well-
defined structure for the linkage region indicates that its assembly could be a 
potential “hot spot” for regulation. On top of that, CS and HS are not functional-
ly equivalent, despite sharing identical linkage regions, which also raises ques-
tions about the regulatory determinants for this biosynthetic bifurcation. 
Notably, the linkage region tetrasaccharide is the target for several substitutions; 
some of them having a regulatory function. 
1.2.4 Chemical substitutions and regulation of the GAG linking tetra-
saccharide  
Previous structural studies of the GAG-protein linkage have revealed the pres-
ence of several substitutions. Phosphorylation at the C-2 position of the linking 
xylose is probably the best studied of these modifications and occurs both on 
CS/DS and on HS chains. Phosphorylation is catalysed by FAM20b, a sugar ki-
nase located in the secretory pathway (Koike et al., 2009). This event is pro-
posed to occur transiently during elongation from Gal-Xyl to Gal-Gal-Xyl 
followed by rapid dephosphorylation after the addition of the GlcA residue 
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(Moses et al., 1997). Bringing further support to that notion, the existence of a 2-
phosphoxylose phosphatase has recently been reported (Koike et al., 2014). The 
C-2 phosphorylation is known to modulate the assembly of the linkage region by 
dramatically increasing the activity of GalT-II (Wen et al., 2014). A certain role 
in regulating the GlcAT-I activity has also been suggested as this glucuronyl-
transferase has an increased preference for phosphorylated substrates (Gulberti et 
al., 2005; Tone et al., 2008). Cells lacking FAM20b are unable to extend the 
tetrasaccharide linkage region and produce instead immature GAG chains, 
capped with a sialic acid modification (Neu5Acα2,3Galβ4Xylβ-O-). Intriguing-
ly, the phosphorylated linkage structures do not support further polymerization 
in vitro (Koike et al., 2014). At the same time, mature phosphorylated GAGs 
have been identified in several cell systems at substoichiometrical levels. If this 
presence is due to incomplete phosphorylation or dephosphorylation is currently 
unknown. It could be possible that in vitro assays do not fully recapitulate the 
true biosynthetic conditions. It is also likely that other factors such as the core 
protein dependence or differences between cellular systems might be important.  
  Contrary to the 2-O-phosphorylation, sulfate substitutions at the C-4 
and/or C-6 positions of the Gal residues have been observed in CS/DS but not in 
HS chains. Therefore, it has been suggested that Gal sulfation might be involved 
in priming the linkage region towards CS/DS biosynthesis. In support for such a 
role, the sulfation of the Gal residues increases the initiation activity and catalyt-
ic efficiency of the CSGalNAcT-1, a critical enzyme that transfers GalNAc onto 
the linkage region and directs the biosynthesis towards CS/DS (Gulberti et al., 
2012). In addition to that, the amino acid sequence of the protein acceptor seems 
also to be critical (Izumikawa & Kitagawa, 2015). Unfortunately, the mechanis-
tic relationships between the specific GAG attachment site, the modifications of 
the linkage region and the final GAG-type have not been fully elucidated. A 
more systematic analysis of all of these modifications (as well as the discovery 
of potential novel ones) is thus required to understand the structural diversity of 
the proteoglycan linkage region and its regulatory role during GAG biosynthesis. 
1.2.5 Structure and biosynthesis of the GAG backbone 
The CS/DS backbone 
 
After completion of the linkage region, the CS/DS backbone is synthetized by 
the alternate addition of GlcA and GalNAc residues. As mentioned before, the 
transfer of the first GalNAc is mediated by the action of the CSGalNAcT-1. An-
other enzyme, CSGalNAcT-2 is primarily involved in the regulation of the chain 
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length and/or the number of chains (Izumikawa et al., 2011). At least three other 
enzymes catalyze the polymerization of the CS/DS backbone: ChSy-1, - 2 and -3 
(chondroitin synthase-1, -2 and -3). These enzymes possess dual catalytic activi-
ty (GlcAT-II and GalNAcT-II) but cannot synthesize the chondroitin chain by 
themselves. Nevertheless, co-expression of any of two of these proteins or their 
individual expression together with the chondroitin polymerization factor 
(ChPF), leads to effective polymerization. The length of the resulting chains 
varies then depending on the enzyme combination (Izumikawa et al., 2008). An-
other important modification of the CS/DS chains is the epimerization of GlcA 
into IdoA. This reaction occurs at the polymer level and not by conversion of 
UDP-GlcA into UDP-IdoA as it was originally proposed. Two epimerases, DS-
epi1 and DS-epi2 have been described in humans (Malmstrom et al., 2012) 
  Sulfation of the CS/DS backbone is probably the most important modifi-
cation of these GAG chains. The sulfation patterns of a given CS/DS chain are 
usually instrumental for their ability to engage protein ligands and mediate bio-
logical functions. They are equally important for the ability of CS/DS chains to 
bind water and create hydrated matrices that absorb compressive loads in carti-
lage. Sulfation can occur on the C-4 and/or the C-6 positions of the GalNAc as 
well as on the C-2 position of the GlcA/IdoA residues. CS/DS disaccharide types 
are classified based on their sulfation patterns (Fig 4).  
Figure 4. CS/DS disaccharides are usually classified based on their sulfation patterns 
and uronic acid stereochemistry. Some of the most common examples are shown here.  
 
To date, seven CS/DS specific sulfotransferases have been characterized (Fukuta 
et al., 1995; Kusche-Gullberg & Kjellen, 2003). All of them utilize the same 
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activated sulfate donor, 3’-phosphoadenosine 5’-phosphosulfate (PAPS) for the 
sulfation reaction. 
 
 
The HS/ Heparin backbone   
                                                                                                                  
At least three enzymes, EXT1, EXT2 and EXTL3 are known to be involved in 
the polymerization of the backbone of HS/Heparin polysaccharides. EXTL3 is 
proposed to be the main enzyme catalyzing the addition of the first GlcNAc onto 
the tetrasaccharide linkage. This is a key step that commits the nascent GAG 
chain towards HS biosynthesis. After initiation, the EXT1/EXT2 polymerase 
complex starts the transfer of alternating GlcNAc and GlcA onto the growing 
polymer. In similarity to CS chains, the HS backbone serves as the target for 
several modifications. N-deacetylation/N-sulfation of the GlcNAc is mediated by 
the action of several NDST enzymes, leading to a typical distribution of distinct 
N-sulfated (NS), N-acetylated (NA) and hybrid (NS/NA) domains. The GlcNAc 
units may also undergo further sulfate substitution at position C-3 and/or C-6, a 
process that is mediated by at least three 6-O-sulfotransferases and seven 3-O-
sulfotransferases. Epimerization of GlcA into IdoA is catalyzed by a single C-5 
epimerase that it is not related to the CS epimerases. Furthermore, the great ma-
jority of the IdoA units become sulfated by a 2-O-sulfotransferase.  
  In general, discrete patterns of sulfate and uronic acid epimers give rise to 
binding sequences for interaction with different ligands. These motifs constitute 
the structural basis for HS-mediated biological functions. Interestingly, despite 
the lack of a template, HS biosynthesis is known to be tightly regulated during 
development (Poulain & Yost, 2015). More importantly, several studies have 
also suggested the existence of tissue-specific HS compositions, which seem to 
imply that the fine structures of HS chains are not randomly generated (Kato et 
al., 1994; Shi & Zaia, 2009). To explain these observations, several regulatory 
models have been proposed, including the potential existence of the HS biosyn-
thetic machinery as multiprotein complexes in the Golgi (GAGosomes) (Esko & 
Selleck, 2002). A “coding and decoding” hypothesis has also been suggested 
where certain primary sulfation events (sulfate code) can be recognized by en-
zymes involved in downstream modification of the HS chains (X. Zhang et al., 
2016). This is an area of intense research.  
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1.2.6 Proteoglycans in health and disease 
Extensive research on the biological roles of GAGs (and proteoglycans) has shed 
new light on their crucial and sometimes unexpected involvement in numerous 
biological processes. Due to the original development of GAG research, two 
main functions were initially ascribed to these polysaccharides. Firstly, a struc-
tural role in connective tissue organization was rapidly acknowledged, particu-
larly in cartilage. Additionally, an important role in controlling blood homeosta-
sis was also realized due to the discovery of heparin and its anticoagulant proper-
ties.  
  Proteoglycan are now known to constitute the major structural component 
of the ECM of cartilaginous tissues. Cartilage ECM is primarily composed of 
aggregates of HA, aggrecan and the link protein. Together, these molecules form 
a gel-like matrix that absorbs compressive mechanical loads through water re-
sorption and desorption. Aggrecan is a high molecular weight proteoglycan that 
contains around 100 GAG chains (Kiani et al., 2002). The GAG chains are most-
ly of the CS type but the presence of KS has also been demonstrated. Altered 
degradation of aggrecan is a hallmark of progressive and degenerative joint dis-
orders such as osteoarthritis (OA), which leads to deterioration of the cartilage 
and fibrosis of the synovium and the joint capsule (Huang & Wu, 2008).  
  Heparin is a highly-modified variant of HS attached to serglycin and 
stored in the secretory granules of mast cells from connective tissues. The en-
dogenous physiological function of heparin is still largely unknown. On the oth-
er hand, its potent anticoagulant activity has been readily exploited in clinical 
settings to prevent venous thrombosis and pulmonary embolism as well as for 
the management of coronary artery disease (Hirsh et al., 2001). The anticoagu-
lant activity of heparin is ascribed to a well-defined pentasaccharide that binds to 
antithrombin and thrombin in a ternary complex (Li et al., 2004). This binding 
leads to inactivation of thrombin and factor Xa, and thus prevents fibrin for-
mation and thrombin-mediated activation of blood platelets.  
  New additional knowledge about the biological importance of GAGs has 
been acquired through lessons from relatively rare genetic disorders where muta-
tions in the GAG biosynthetic machinery have been reported (Mizumoto et al., 
2013). Accumulating data clearly indicates that GAGs are essential for normal 
bone development and for the maintenance of skin integrity in humans. In addi-
tion, defects in GAG catabolism are the main cause of a number of inherited 
lysosomal storage disorders collectively known as mucopolysaccharidoses 
(Muenzer, 2011). Advances in genetic manipulation techniques and new experi-
mental models have enabled the exploration of additional roles for these versatile 
molecules in both health and disease. Surprisingly, the data to date seems to im-
plicate GAGs, in a complex manner, in a plethora of fundamental processes such 
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as development, stem cell biology, immunity, wound healing as well as in path-
ogen infection and cancer. As a comprehensive covering of these areas is clearly 
out of the scope of this thesis, only a few examples will be selected to illustrate 
general principles related to GAG biology and pathogenesis. Some of these ex-
amples will also be revisited in the next sections in the light of the specific re-
sults generated during this thesis.   
   
Perlecan in cancer and angiogenesis 
 
Perlecan is a large basement membrane proteoglycan and a key component of 
the vascular ECM. It consists of a high molecular weight core protein (~470Da) 
that it is heavily decorated with multiple glycans including the attachment of 
three HS chains at the N-terminus. The first indications of perlecan being in-
volved in cancer and angiogenesis came from reports describing a dramatic ex-
pression and deposition of perlecan in highly invasive melanomas (Cohen et al., 
1994). Later on, it was found out that perlecan acts as a co-receptor for the fibro-
blast growth factor (FGF2), a well-established pro-angiogenic factor (Aviezer et 
al., 1994). More importantly, suppression of perlecan in melanoma cells from 
both human and murine origins blocks the autocrine and paracrine functions of 
FGF2 and suppresses proliferation and invasion (Aviezer et al., 1997). In simi-
larity with other HS proteoglycans, perlecan interacts with many different 
growth factors through its GAG chains. Interestingly, transgenic animals lacking 
the perlecan domain where the GAG chains are attached show impaired tumor 
growth and FGF2 mediated angiogenesis (Zhou et al., 2004). Furthermore, the 6-
O-sulfation of HS chains has been implicated in the regulation of the angiogenic 
response of endothelial cells to FGF2 and to the vascular endothelial growth 
factor (VEGF) (Ferreras et al., 2012). Endothelial-targeted deletions of NDST1, 
a key enzyme in the N-deacetylation and N-sulfation of HS, impair angiogenesis 
and reduce tumor growth in murine experimental systems (Fuster et al., 2007). 
Collectively, the data points to a major pro-angiogenic role for perlecan in tumor 
neovascularization and highlights the importance of the HS fine structure for 
these processes. 
  As is certainly the case for other proteoglycans, perlecan is also the target 
for proteolytic events that liberate biologically active fragments from its core-
protein. Endorepellin is a C-terminal fragment of perlecan that it is generated by 
the action of an endopeptidase called cathepsin L (Cailhier et al., 2008; Mongiat 
et al., 2003). In turn, the bone morphogenetic protein 1 (BMP1) can act on en-
dorepellin leading to the proteolytic release of a soluble LG3 domain (Gonzalez 
et al., 2005). Notably, both endorepellin and its LG3 domain can trigger a signal-
ing cascade in endothelial cells that prevents them from establishing capillary 
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morphogenesis in several angiogenic assays (Bix et al., 2004). Recent studies 
have conclusively established an anti-angiogenic role for these two bioactive 
fragments through the modulation of specific integrin signaling pathways 
(Douglass et al., 2015). These interesting findings underscore the importance of 
proteoglycans and their GAG chains for modulation of key processes, such as 
tumor angiogenesis, through their binding to growth factors. They also exempli-
fy how proteolytic events can generate protein fragments with a distinct biologi-
cal activity, sometimes completely different from the precursor core protein. 
However, if GAG glycosylation itself could be a modulating factor for the prote-
olytic processing, as it has been shown for other types of glycan modifications 
(Goth et al., 2015), has not been fully addressed. 
 
VAR2CSA and pregnancy-associated malaria infection 
 
Many GAGs can be targeted by microbial pathogens (and virulence factors) for 
adhering and invading host cells. Several studies have shown that GAGs can 
also modulate systemic microbial dissemination and immune evasion (Bartlett & 
Park, 2010). One example of such a GAG-pathogen interaction is exemplified by 
the acquired ability of malaria-infected erythrocytes (IEs) to evade immune 
clearance by engaging GAG receptors in the placenta during pregnancy-
associated Plasmodium falciparum infection (Fried & Duffy, 1996). The adhe-
sion and sequestration of IEs in the placenta is mediated by the expression of the 
malaria VAR2CSA protein in the membrane of IEs (Reeder et al., 1999). The 
placental receptor for the VAR2CSA protein is a distinct subset of chondroitin-
4-sulfate (CSA) specifically attached to the core-protein of syndecan-1 in the 
intervillous space and the syncytiotrophoblasts (Ayres Pereira et al., 2016). CSA 
is expressed in many other locations of the microvasculature but Var2CSA-
binding is only supported in the placenta. This suggests unique structural fea-
tures for placental CSA but the structure of the exact binding sequence has not 
been fully determined. Pregnancy-associated malaria is highly correlated with 
maternal anemia, spontaneous abortion, and stillbirth (Brabin et al., 2004).   
  Surprisingly, it has been recently shown that placental-type CSA is also 
expressed in a broad array of human malignant cells but not in healthy tissues 
(Salanti et al., 2015). This CS-signature has been re-named to oncofetal-CS and 
can be specifically targeted by recombinant VAR2CSA constructs. Contrary to 
the placental setting, oncofetal-CS expression in cancer appears to be heteroge-
neous as to the core-protein identities but further studies are needed to address 
this issue. Still, the presence of a common GAG-signature in cancer cells opens 
new avenues for diagnosis and therapeutic interventions. As it will be discussed 
later, some of the results in this thesis indicate that oncofetal CS expression is 
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also present in pluripotent stem cells and might be a signature for highly prolif-
erative and undifferentiated cellular states.  
 
Proteoglycans in development and stem cell biology 
 
The importance of GAGs for development was initially recognized since muta-
tions in enzymes involved in Drosophila HS biosynthesis were linked to im-
paired signaling through the WNT, FGF and Hedgehog pathways (Bornemann et 
al., 2004; Haerry et al., 1997). This led to severe defects in cell differentiation 
and morphogenesis (Hacker et al., 2005). Later, several lines of inquiry have 
established HS chains as essential regulators of morphogen gradient formation 
(Hayashi et al., 2012; Kleinschmit et al., 2010; Yan & Lin, 2009). In vertebrates, 
HS polysaccharides play an important role in modulating early developmental 
processes such as left-right patterning and neuronal and cardiovascular develop-
ment (Arrington et al., 2013; Pan et al., 2014). Lineage-specific expression of the 
HS biosynthetic machinery has also been demonstrated (Nairn et al., 2007; Yabe 
et al., 2005). These findings, together with the tight developmental regulation of 
the HS fine structures, suggest the existence of an instructive HS “sugar code” 
for vertebrate development (Poulain & Yost, 2015). However, this concept re-
mains controversial and needs further confirmation.  
  The impact of CS on similar developmental processes is currently less 
well understood. However, recent reports have provided evidence for a critical 
role under early embryogenesis. For example, CS proteoglycans are required for 
embryonic cell division and cytokinesis in both C. elegans and mice (Hwang et 
al., 2003; Izumikawa et al., 2010; Mizuguchi et al., 2003). They are also indis-
pensable for pluripotency and self-renewal of embryonic stem cells (ESCs) 
(Izumikawa et al., 2014). Interestingly, HS becomes critically relevant during 
exit of self-renewal by facilitating FGF signaling (Kraushaar et al., 2013). These 
results emphasize the notion that HS and CS are not functionally equivalent, and 
that the spatiotemporal regulation of different GAG types is an important re-
quirement for normal early development. The mechanistic basis for these pro-
cesses is still poorly defined.  
1.2.7 Summary 
Initially ascribed with an exclusive structural role, the GAGs (and the proteogly-
cans) have slowly found their way into the mainstream of biological research. 
Their impact on fundamental biological processes has brought together research-
ers from different fields, ranging from biomaterial engineers to oncologists and 
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developmental biologists. Their role in widespread diseases has become obvious 
and led to the exploration of novel diagnostic and therapeutic strategies. On the 
other hand, the current lack of high throughput methodological tools has ham-
pered a faster development for the field and many difficult challenges remain.  
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2. Methodological considerations 
2.1 Analytical challenge 
From a scientific-philosophical point of view, I will argue that modern biochem-
istry is embedded in a theoretical framework, which can be described as “a struc-
ture and function paradigm”. In other words, our current understanding of the 
biological world is based on the premise that structural determinants mediate 
chemical interactions, which in turn, are the main drivers of biological functions. 
Translated to the setting of glyco-analysis, most methodological approaches in 
glycobiology are generally concerned with one of these three aspects of glyco-
sylation: i) the characterization of glycan structures and the mechanisms regulat-
ing their assembly, ii) the detailed understanding of glycan-protein interactions 
and iii) the assessment of glycan-mediated biological functions as they correlate 
to specific glycan structures. 
  This thesis is primarily concerned with the partial structural characteriza-
tion of proteoglycans. Currently, no single technique can uncover all the struc-
tural details of a given glycoconjugate and the structural glycobiologist must rely 
on a broad array of methodologies to acquire different layers of structural under-
standing. The choice of methodology is also dictated by the amounts and purity 
of the available material. Ideally, the complete structural characterization of a 
proteoglycan will include at least five different variables:  
 
 The identification of the core-protein and the GAG attachment site(s)  
 
 The establishment of the glycan composition (i.e. number and type of 
monosaccharides and substituents) 
 
 The establishment of the glycan sequence (i.e. the order of constituent 
monosaccharides and their substituents as well as their linkage configu-
rations and positions) 
 
 A measurement of the macroheterogeneity (glycan occupancy) 
 
 A measurement of the microheterogeneity (diversity of glycoforms) 
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2.2 Purification of GAGs and proteoglycans 
Before structural analysis is conducted, the proteoglycans need to be isolated 
from different biological sources, typically from cell cultures, tissues, organs or 
body fluids. As discussed before, many proteoglycans constitute scaffolds for 
organizing ECMs and engage in binding to multiple proteins. For that reason, 
some of them are resistant to extraction in solvents that preserve molecular asso-
ciations. Tough dissociative conditions are typically required to break down such 
macromolecular interactions (Fedarko, 1994; Whitelock & Iozzo, 2002). Given 
that some proteoglycans are also membrane-bound, the use of detergents is usu-
ally recommended to achieve optimal extraction. In general, the protocols for 
proteoglycan purification take advantage of the physicochemical properties that 
distinguish proteoglycans from other biomolecules. These include a high density 
of negative charges, large hydrodynamic sizes, and high buoyant density.  
  Anion exchange chromatography is a suitable step for general proteogly-
can enrichment. Typically, a positively charged matrix is used to interact with 
negatively charged groups such as the uronic acids and the sulfate substituents of 
the GAG chains. Bound molecules are then displaced by increasing salt concen-
tration or changing the pH. Although this method is quite unspecific, (all types 
of GAGs are enriched), it allows for both purification and concentration in a 
single step. In fact, this technique alone can provide crude proteoglycan prepara-
tions of sufficient purity for further analysis. On the other hand, some acidic 
proteins or nucleic acid may also adhere to the column, requiring endonuclease 
treatment and/or further purification steps. The presence of salts in the elution 
buffers may also interfere with downstream analysis, especially if mass-
spectrometric detection is desired. 
  Anion exchange chromatography can be combined with other purification 
methods to improve the isolation of proteoglycans. Most proteoglycans have 
large hydrodynamic sizes due to the contribution of the GAG chains. Size exclu-
sion chromatography (SEC) has traditionally been used for fractionation of intact 
molecules as well as for separating oligosaccharide products of GAG depoly-
merization reactions (Zaia, 2009). Another advantage is that SEC can provide an 
estimation of the average weight of the fractionated components. Additionally, 
most proteoglycans possess high buoyant densities in CsCl equilibrium density 
gradients (Meselson et al., 1957). This facilitates their sedimentation by ultracen-
trifugation but this approach only works for proteoglycans with high GAG- pro-
tein ratios. In general, there is no single purification protocol that works for all 
proteoglycans and the conditions must be empirically determined for each exper-
imental system. Other variables such as the biological source, the starting 
amounts of material and the downstream analysis must also be taken into con-
sideration.   
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2.3 Proteoglycan structural analysis 
Proteoglycans are complex molecules and their detailed characterization de-
mands the analysis of several structural levels. One way of simplifying the task 
is separating the GAG chains from the core protein either by proteolytic diges-
tion or through chemical release. Exhaustive treatment with mixtures of proteas-
es such as pronase has been used to digest the proteoglycan core-proteins into 
glycopeptides consisting of an intact GAG chain attached to the linking serine 
residue. These glycopeptides can be further isolated and concentrated by anion 
exchange chromatography or similar purification approaches. An alternative to 
this method is the chemical release of the GAG chains by base-catalyzed β-
elimination under reducing conditions. This well-established procedure gener-
ates a xylitol residue at the GAG reducing end (Seno & Sekizuka, 1978).  
  Irrespectively of which approach is applied, the released GAGs (or glyco-
peptides) are usually digested by GAG-specific lyases to depolymerize the gly-
can chain into a pool of constituent disaccharides. This is a powerful way of 
reducing the heterogeneous GAG populations into sequence representatives of 
the average structure. An increasing number of studies have shown that the anal-
ysis of digested GAG chains can be used to derive structure-and-function rela-
tionships in relevant biological contexts (Ly et al., 2010). Partial depolymeriza-
tion can also be achieved to generate oligosaccharides that are suitable for gly-
can sequencing. The analysis of intact GAGs and depolymerization products can 
be conducted using different glyco-analytical techniques (Bielik & Zaia, 2010). 
However, biological mass spectrometry (MS) has largely emerged as the pre-
ferred platform for glycan structural analysis.  
2.4 Mass spectrometry  
Mass spectrometry (MS) is one of the most important micro-analytical tech-
niques in modern glyco-analysis. In principle, MS is based on the generation of 
gas-phase ions of a compound (the analyte) followed by the accurate measure-
ment of its mass-to-charge (m/z) ratio. In this way, the elemental composition of 
the analyte can be determined. Most modern MS instruments support dissocia-
tive techniques to induce fragmentation of selected ions to generate a secondary 
mass spectrum (MS2). The product ion pattern in MS2 often contains new infor-
mation about the composition and structure of the molecule of interest. Multi-
stage fragmentation (MSn) is currently possible, increasing the degree of struc-
tural insight that can be derived from such experiments. One of the reasons for 
the total dominance of MS in biochemical analysis has to do with the fact that no 
other technique is capable of producing more structural information per unit 
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quantity of an analyte. The advent of “soft” ionization methods such as elec-
trospray ionization (ESI) and matrix-assisted laser desorption/ionization 
(MALDI) has made possible the direct analysis of femtomole quantities of non-
volatile and thermally labile compounds such as proteins and glycans, even in 
relatively complex biological samples. As ESI was used throughout this thesis, a 
short description of its basic principles is pertinent.  
 
Electrospray ionization 
 
ESI is achieved in the ion source by spraying a solution of the analyte through a 
small capillary into an electric field. An electric potential is typically established 
between the tip of the capillary and a counter electrode. The electrospraying 
leads to the formation of an aerosol of highly charged droplets at atmospheric 
pressure and the polarity of the electric potential will determine if positively or 
negatively charged ions are formed. These initial droplets are made to shrink by 
a drying gas through solvent evaporation. As droplets evaporate and diminish in 
size, they become unstable due to an increase in the electric charge density on 
their surfaces. Repulsive forces between equal charges make the droplets “to 
explode” generating even smaller droplets. Although several mechanisms have 
been proposed for the last step of ESI (Wilm & Mann, 1994), it always results in 
the complete evaporation of the solvent yielding a continuous beam of gas-phase 
ions. Modern nano-ESI generates ion droplets 10-fold smaller than traditional 
ESI eliminating certain stages of droplet division and facilitating greater ioniza-
tion efficiency and stronger signals (Karas et al., 2000). 
  Compared to older ionization techniques, ESI imparts relatively low ener-
gy to the molecules during desolvation. For that reason, it is considered a soft 
ionization method that prevents “in source” metastable decay. As the ions are 
generated directly from solution, ESI constitutes a perfect interface for liquid 
chromatography (LC) coupled to MS detection. ESI tends also to produce ions 
carrying multiple charges and the m/z ratios of most biomolecules fall within the 
detection range of commonly used MS analyzers. On the other hand, the pres-
ence of contaminants such as salts and plastic polymers can severely affect the 
ionization process, which makes sample preparation for ESI more demanding 
than for other alternative techniques such as MALDI. 
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MS analysis   
 
After ESI, the ions are led into a mass analyzer device to allow for accurate m/z 
measurements, and in certain applications, for controlled fragmentation of se-
lected precursor ions. There is a large variety of MS instruments (including hy-
brid types) that are routinely used for biomolecular analysis. The reliable 
identification of biomolecules in complex mixtures requires robust and sensitive 
MS instrumentation with high resolving power, mass accuracy, and wide dynam-
ic range. Recently, the Orbitrap analyzer has proven to be a popular high-
resolution instrument due to its relatively low cost, its flexibility in hybrid con-
figurations and its exceptional high-performance, mass accuracy and resolution 
(Hu et al., 2005).  
  One of the central features of the Orbitrap is its specific geometry. In the 
Orbitrap, a DC voltage is applied between a spindle-like inner electrode and a 
barrel-like outer electrode. This static electric field creates stable rotatory ion 
trajectories around the central electrode as well as oscillations in the axial z-
direction. The axial frequency is used to derive the m/z ratio of an ion package. 
The axial oscillations are independent of both the initial properties of the ions 
and the orbiting motions around the central electrode. This independence is the 
main parameter responsible for the high accuracy and mass resolving power of 
the Orbitrap (Makarov, 2000). The axial oscillations generate an image current 
in the outer electrode that is acquired as a time-domain transient and converted 
into frequencies (and m/z) by Fourier transformation. Commercially available 
Orbitraps can achieve mass accuracies of 2-5 ppm, a linear dynamic range of up 
to four orders of magnitude, and a mass resolution of up to 150,000.  
  Orbitraps can also be combined with other devices such as a quadrupole 
mass analyzer to create a composite instrument that allow for a more flexible ion 
manipulation. In typical hybrid configurations, such as the Q Exactive instru-
ment used during this thesis work, the quadrupole can be used as a mass filter 
device (Michalski et al., 2011; Scheltema et al., 2014). As the name already in-
dicates, the quadrupole consists of four parallel metal rods where RF and DC 
voltages are established. Ions travelling through the space between the rods can 
be manipulated by changing the voltages so that only molecules of a specific m/z 
ratio can move in stable trajectories while all the other ions will collide with the 
rods. The selected ions can then be transferred to the storage or fragmentation 
devices before Orbitrap analysis. 
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Collisional dissociation  
 
Although accurate mass measurements alone can sometime lead to the identifi-
cation of a compound, it is more often the case that fragmentation of the analyte 
is additionally required to generate structural information. Dissociation of mo-
lecular ions in the gas-phase can be achieved by different fragmentation tech-
niques (Sleno & Volmer, 2004). Independently of the approach, the main goal of 
such experiments is to achieve a controlled decomposition of a selected mole-
cule, following predictable fragmentation rules and yielding product ions that 
can aid in establishing the identity and the structure of the targeted compound. 
The fragment ions are then collected and their m/z ratio is determined. Some 
instruments support multistage fragmentation where selected fragment ions can 
undergo a new round of fragmentation (MSn).  
  Collisional-induced dissociation (CID) is a common technique to achieve 
molecular ion dissociation in the gas-phase. The ions are accelerated and al-
lowed to collide repeatedly with neutral molecules, usually an inert gas, inside a 
collision chamber. The kinetic and collisional energy is converted into internal 
energy and dissipated across the molecule leading to bond dissociation and the 
generation of fragment ions and neutral losses. In the case of glycans, the frag-
mentation of glycosidic bonds is often favored but exactly which product ions 
are formed is also dependent on the collisional energy. Higher-energy dissocia-
tion (HCD) is a beam-type CID specific to the Orbitrap. Fragmentation takes 
place in a HCD cell outside the Orbitrap and the ions pass through a curved 
shaped ion trap (C-trap). The C-trap is critical for Orbitrap measurements as it 
squeezes electrodynamically the ion package in time and space followed by 
pulse-injection into the Orbitrap. Otherwise, the static electric field of the Or-
bitrap would not result in efficient trapping of the ions and they would just pass 
through the device. In some configurations, the fragmentation can actually take 
place inside the C-trap itself (Olsen et al., 2007).  
2.5 MS-based GAG analysis 
GAGs are long and intrinsically polydisperse molecules. After release of the 
intact glycan from the core protein, GAGs are often subjected to complete or 
partial enzymatic depolymerization. Commercially available CS and HS degrad-
ing enzymes act through an eliminative mechanism (lyases) to cleave the 
HexNAc-HexA bonds. This cleavage generates 4,5-unsaturated HexA (ΔHexA) 
at the non-reducing end of the disaccharides and of the hexasaccharide contain-
ing the linkage region. The specificity of individual enzymes can be exploited to 
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gain access into the polysaccharide structures (Ernst et al., 1995). Chemical 
treatments for achieving cleavage of N-sulfated domains of HS/Heparin are also 
commonly used. The released disaccharide pool can be further fractionated and 
subjected to quantitative analytical methods including several derivatization 
schemes combined with chromatographic separation and fluorescence detection 
(Zaia, 2009). However, MS approaches have become increasingly popular, espe-
cially in combination with a wide range of liquid chromatography (LC) strate-
gies. 
  The MS analysis of GAG disaccharides is often conducted in negative 
mode ionization but positive mode with ion-pairing reagents has also been re-
ported (Juhasz & Biemann, 1994, 1995).  In general, the sulfate groups tend to 
dissociate as the internal energy of the molecule increases, which demands low 
desolvation energies to prevent metastable decay during ionization. Additionally, 
during fragmentation experiments in negative mode, the dissociation of the sul-
fate groups is largely dependent on the charge state of the precursor ion and the 
amount of collisional energy (Staples & Zaia, 2011; Zaia & Costello, 2001). 
Currently, ESI is considered the gentlest ionization method for disaccharide 
analysis but fine-tuning of the MS operating settings remains crucial for success. 
Given that ion efficiency differs between the expected disaccharides, the use of 
defined standards is also paramount to enable quantification in unknown sam-
ples. Differentiation of isobaric structures, for example ΔHexA-GalNAc(6S) vs 
ΔHexA-GalNAc(4S) can be achieved by MS/MS fragmentation and analysis of 
the product ion pattern (Desaire & Leary, 2000). The analysis of larger GAG 
oligosaccharides is also possible but the complexity of the resulting MS spectra 
is far more challenging. On the other hand, while disaccharide determination is a 
good way of deriving the average composition of a GAG chain, direct oligosac-
charide sequencing allows for domain characterization and provides an overview 
of biologically relevant sequences. Notably, the sequencing of the entire GAG 
chain of bikunin and decorin has recently been reported (Ly et al., 2011; Zhao et 
al., 2013). The remarkable results from those studies point to the existence of 
surprisingly well-defined GAG sequences in native proteoglycans, challenging 
our current understanding of their biosynthesis and their structure-and-function 
relationships.  
2.6 Glycoproteomics 
Although detailed structural information can be obtained by releasing or separat-
ing the GAG chains from the proteins, such approaches cannot provide the iden-
tity of the carrier protein and the site(s) of glycan attachment. This information is 
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critical to assign specific functions to particular proteoglycans and to evaluate 
the impact of site-specific GAG modification on biologically relevant contexts. 
In addition, glycans appear as arrays of related structures attached to the same 
position on the aglycone (microheterogeneity) and their occupancy (macroheter-
ogeneity) may vary, which cannot be effectively addressed without maintaining 
the connection between the glycan and the protein. In principle, these methodo-
logical concerns are not only important for proteoglycans but also for the analy-
sis of all N- and O-glycoproteins. The protein information has traditionally been 
obtained through standard biochemical techniques such as western blots and/or 
site-specific mutagenesis or inferred from mRNA expression data. The problem 
here is that such methods cannot be applied in a system-wide fashion and require 
a-priori knowledge of the relevant glycoproteins before analysis.   
  During the last years, new MS-based approaches have emerged that spe-
cifically address these difficult issues. Glycoproteomics is a new field that fo-
cuses on the system-wide site-specific study of the glycoproteome (Nilsson et 
al., 2013; Thaysen-Andersen & Packer, 2014). The main molecular targets for 
glycoproteomics are usually glycopeptides generated by protease-digestion of 
glycoproteins. Many different strategies and workflows have been reported dur-
ing the last two decades including the engineering of the glycosylation by ge-
nome editing or through metabolic labeling, the development of new enrichment 
protocols and LC-separation schemes, and the use of new fragmentation tech-
niques (Hinneburg et al., 2016; Nilsson et al., 2009; Steentoft et al., 2011; 
Vester-Christensen et al., 2013; H. Zhang et al., 2003). In similarity to MS-based 
glycan analysis, glycoproteomics approaches are not general in nature and need 
customization that takes carefully into account the biological source, the glycan 
structures and the desired level of structural information. Currently, glycoprote-
omics data can account for the composition of the glycan chain, the glycosyla-
tion site(s) and the identity of the carrier core protein. Unfortunately, other 
“high-resolution” glycan information such as the glycosidic linkage positions 
and α/β-configurations has not been demonstrated at the glycopeptide level. In 
the same line, it has been widely assumed that the identity of isobaric monosac-
charides cannot be determined by these approaches although new data, including 
the findings from this thesis, have started to challenge that notion (Halim et al., 
2014; Hofmann et al., 2015; Sarbu et al., 2015; J. Yu et al., 2016).  
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2.7 Glycoproteomics tools for proteoglycan analysis 
 
During the course of this thesis, we started developing MS-based glycoprote-
omics approaches for the global analysis of CS/DS- and HS- proteoglycans from 
biological fluids and cell cultures. To our knowledge, only one single study has 
been reported so far by another group where the potential of high-throughput 
biological MS has been directed to answer questions regarding the identity and 
attachment sites of CS-proteoglycans (Olson et al., 2006). In that study, nine 
novel CS-proteoglycan core-proteins were simultaneously identified in C. ele-
gans by releasing the GAG chains through beta elimination and tagging the gly-
cosylation sites with DTT, followed by LC-MS/MS analysis. Compared to 
traditional approaches, where a combination of several complicated biochemical 
techniques where required to identify one single proteoglycan, the possibility of 
getting high-throughput data in a single experiment is quite an achievement. Ob-
viously, these experimental setups were applied at the expense of losing infor-
mation on the fine-details of the GAG chains, and can be considered comple-
mentary to other glyco-analytical tools. However, the number of currently 
known proteoglycans is very small compared to other glycosylation events. This 
fact could probably reflect the limited protein preferences for GAG modification 
but also technical difficulties in obtaining the protein identities of novel proteo-
glycans and/or a large bias towards disregarding the core proteins as mere pre-
senters of GAG chains.  
 In the present work, we took advantage of the fact that commercially 
available GAG-degrading enzymes, in addition to disaccharides, leave a hexa-
saccharide structure covering the linkage region still attached to the protein. We 
set up a simple protocol using proteolytic digestion, anion exchange chromatog-
raphy and GAG depolymerization, to obtain what it is referred throughout this 
thesis as proteoglycan linkage region glycopeptides (Fig.5). These glycopeptides 
turned out to be suitable targets for different LC-MS/MS analytically strategies 
yielding information on completely novel core-proteins and allowing for the site-
specific analysis of hybrid proteoglycans. This analysis also gave insights into 
the combinatorial possibilities of the proteoglycan linkage region, including the 
identification of novel glycan modifications. We also developed SweetNET, a 
robust bioinformatics workflow to handle hundreds of thousands of MS/MS 
spectra generated by these glycoproteomics experiments and showed its general 
applicability not only to the linkage-region glycopeptides but also to N-and O-
glycopeptides. Finally, we also demonstrate how these new tools can be used to 
address biologically relevant problem such as the detailed analysis of the expres-
sion of oncofetal CS in cancer and iPS cells. 
 
44   2 .  MET HOD OLO GI CAL CON SIDE RATI ONS
 
 
Figure 5. General workflow developed in this thesis to generate and analyze proteoglycan 
linkage region glycopeptides. During the analysis of heparan sulfate proteoglycans the 
Chondroitinase ABC step is substituted with heparinase I-III treatment. 
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3. Aims 
The general aim of this thesis was to develop a comprehensive glycoproteomics 
workflow for the global characterization of CS/DS- and HS- proteoglycans from 
complex biological samples. Our main hypothesis was that traditional approach-
es for glycosaminoglycan characterization can be combined with global prote-
omics/glycoproteomics techniques to gain insights into multiple aspects of the 
proteoglycan structures that are not covered by current methodologies. If suc-
cessful, we hypothesized that such approaches should facilitate addressing gen-
erally unresolved issues regarding glycosaminoglycan attachment sites, glycan 
structural variations and also eventually expand the number and types of proteo-
glycans found in nature. For overcoming the technical difficulties, we hypothe-
sized that starting with the simplest and most easily available proteoglycans and 
successively, in a step-by step manner, expanding into the various classes of 
proteoglycans would be the most efficient way to work.  
 
The specific aims were to: 
 
 Develop methods for the generation and LC-MS/MS structural charac-
terization of linkage region glycopeptides derived from CS- and HS- 
proteoglycans  
 
 Develop a robust bioinformatics platform to effectively handle high-
throughput glycoproteomics data  
 
 Apply glycoproteomics tools to assess the site-specific expression of 
CS in iPS and cancer cells 
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4. Results and discussion 
4.1 Targeting the data 
Choosing optimal MS conditions 
 
Glycopeptides are hybrid molecules composed of a glycan and a peptide moiety 
and both components will simultaneously contribute to their average physico-
chemical properties. As glycans and peptides are chemically different, it is often 
hard to find optimal conditions for the chromatographic and MS analysis of gly-
copeptides. Usually a combination of approaches is required. Furthermore, pro-
teoglycan-derived glycopeptides are substituted with labile sulfate groups. A 
typical problem during collisional fragmentation of sulfated glycopeptides is that 
structurally informative bonds have different kinetics of dissociation, in the order 
from weaker to stronger: sulfate ester bonds => glycosidic bonds => peptide 
bonds. The gas-phase fragmentation of glycosylated peptide ions is also com-
plex. In fact, several dissociation pathways may co-exist and their balance is 
dependent on the method chosen as well as on the composition and charge of the 
analyte (Dodds, 2012).  
  In Paper I and II, we explored MS conditions to obtain structural infor-
mation from proteoglycan linkage region glycopeptides. Instead of combining 
orthogonal fragmentation techniques we decided to stick to HCD as it yielded 
both glycan and peptide fragmentation in a single step. At the same time, the 
level of the input energy can be easily fine-tuned which turned out to have a ma-
jor impact on the fragmentation of our target analytes. For example, in Paper II 
we found that HCD fragmentation at low energies facilitates dissociation of the 
glycosidic bonds at the expense of the peptide fragmentation. From such exper-
iments, the composition and sequence of the modifying glycan could be estab-
lished. Increasing the energy resulted in the opposite outcome, yielding good 
peptide fragmentation but the glycans were completely lost. We developed then 
a strategy where each precursor ion underwent sequential or parallel fragmenta-
tion at different energy levels. As it is shown in Paper II, this resulted in im-
proved structural determination of the linkage-region glycopeptides but the 
substituents, especially sulfates, were still dissociated as neutral losses. Full 
deprotonation can compensate for the fragility of sulfate groups e.g. by conduct-
ing the fragmentation in negative mode or by using ion-paring reagents. As dis-
cussed before, negative mode is a natural analytic choice for GAG 
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oligosaccharides as it increases the stability of the sulfate groups. Unfortunately, 
fragmentation of linkage glycopeptides in negative mode does not produce 
enough peptide fragments, which hinders a high-throughput strategy for the 
identification of the core-proteins (Fig 6). 
 
 Figure 6. MS/MS spectrum of a CS-linkage region glycopeptide derived from human 
urinary bikunin. The analysis was conducted in negative mode ionization and illustrates 
the absence of informative peptide fragmentation. 
 
For that reason, most of the experiments in this thesis were conducted in positive 
mode, despite the obvious loss of the sulfate substituents. However, we also 
show in Paper II that cation complexation through Na+/H+ exchange is a good 
way of achieving stabilization of the sulfates. Such parallel experiments were 
conducted for pinpointing their position on the glycan chain. Summarizing, the 
hybrid nature of our targeted glycopeptides required the parallel or sequential 
use of different techniques. The amount and complexity of the output data also 
demanded the development of robust bioinformatics tools for data handling.  
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SweetNET: Organizing and clustering the data  
The bioinformatics treatment of glycoproteomics data poses many challenges. 
One major difficulty compared to other molecules lies on an exponential in-
crease in the search space as the combinatorial possibilities depend on variations 
regarding both the peptide sequences and the glycan units. Currently, there is a 
lack of glycopeptide spectral libraries for structural matching and common pro-
teomics-oriented peptide-spectrum match (PSM) algorithms tend to underesti-
mate the confidence of modified peptides. These shortcomings are usually 
compensated for by time-consuming “manual verification” being strictly de-
pendent on high competence of single individuals. During the last few years, 
some steps have been taken to develop glyco-bioinformatics tools to address 
these problems. In Paper III, we developed SweetNET, a bioinformatics platform 
for handling high-throughput glycopeptide MS/MS data in a unified semi-
automatic environment. Compared to current approaches, SweetNET contributes 
with the idea that the organization of the data based on glycopeptide-specific 
spectral features and molecular networking, facilitates MS-based structural as-
signment. The workflow was tested on data from different enrichment protocols 
showing that not only proteoglycan-derived glycopeptides but also typical N-and 
O- glycopeptides, can be effectively addressed in our platform.  
  One pivotal aspect that SweetNET considers is the presence of glycan-
derived oxonium ions generated through the collisional dissociation of glycocon-
jugates. These oxonium ions constitute fingerprints for the presence of glycopep-
tides and the SweetNET software exploits them for data filtering and grouping. 
We have previously shown that decomposition of GalNAc or GlcNAc yields 
different oxonium ion intensity profiles (Halim et al., 2014; J. Yu et al., 2016). 
These profiles are automatically computed in the workflow to provide the sac-
charide identity of the N-acetylhexosamines. This information is used to distin-
guish between various types of glycans and core-structures, taking a further step 
into obtaining “high resolution” glycan information from glycoproteomics data. 
More specifically, in Paper III, we show that separation of N-glycans from O-
glycans or even different O-glycan core-structures can be established by this 
method, even before the identity of the whole glycopeptide is obtained.  
  Another characteristic of glycopeptides is that the glycan moiety often 
appears as an array of glycoforms. This inherent microheterogeneity is difficult 
to tackle, as it requires predicting all possible saccharide permutations, which 
often translates into the need for a certain pre-knowledge of the expected glycan 
modifications in the sample. SweetNET handles this problem by incorporating 
the concept of molecular networking (Bandeira, 2007; Guthals et al., 2012; 
Nguyen et al., 2013). In such approaches, spectral similarities between structur-
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ally related compounds are exploited to cluster the MS/MS data. Consensus 
identification is then derived from sets of similar spectra facilitating the discov-
ery of unexpected modifications. Integration of oxonium ion intensity profiles 
and spectral clustering are thus the main novel features of SweetNET. The power 
of this bioinformatics workflow is exemplified in Paper III where the analysis of 
hundreds of thousands of glycopeptide MS/MS spectra was completed during a 
few hours resulting in the structural characterization of 165 N-, 215 O- and 23 
CS-glycosylation sites from around 200 human core proteins. Additionally, it 
also led to the identification of novel fucose modifications in the linkage region 
of several human urinary CSPGs. However, one important weakness of Sweet-
NET in its current format is that it lacks a robust method for estimating the false 
discovery rate. This will therefore be addressed in future developments of the 
software.   
4.2 Targeting the protein 
Identification of novel proteoglycan core-proteins 
 
One of the major findings of this thesis is the identification of novel core-
proteins carrying GAG modifications. Several attempts to develop a classifica-
tion system for proteoglycans have been reported before (Iozzo & Murdoch, 
1996; Iozzo & Schaefer, 2015). In contrast to the GAG chains, the core-proteins 
are far more divergent and encompass gene products with different structures, 
cellular locations and functions. A careful review of the literature also reveals 
that the evidence for GAG attachment on specific proteins ranges from solid to 
circumstantial, depending on the choice of methods and biological systems. 
Hitherto, the most recent nomenclature for vertebrate proteoglycans encom-
passes 43 core-proteins. This classification is based on three different criteria: 
cellular localization, gene/protein homology and domain architecture. Based on 
the literature and the data presented in this thesis, the number of vertebrate pro-
teoglycans can be expanded to 77 genes (Fig 7). The development of more sensi-
tive technologies and the systematic exploration of new biological sources will 
most likely increase this number in the future. In this context, the confirmation 
of 23 previously established proteoglycans and the identification of 21 novel 
ones, show that glycoproteomics is a powerful tool for such an endeavour. 
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Figure 7. Summary of all known vertebrate proteoglycan core proteins. All novel proteo-
glycans identified during this thesis are marked in red.   
 
  During several years, serglycin (SRGN) was largely believed to be the 
only true intracellular proteoglycan. Several groups have also reported that 
Chromogranin A (CHGA), a member of the granin family located in the secreto-
ry vesicles of neurons and endocrine cells, is also a potential carrier of CS modi-
fications (Barbosa et al., 1991; Gowda et al., 1990). As it is shown in Paper I, we 
could confirm the proteoglycan status of CHGA and provided, for the first time, 
the exact site for GAG attachment. Two other members of the granin family, 
Chromogranin B and Secretogranin 3 were also identified carrying GAG modifi-
cations. Apart from being precursors to various bioactive peptides, the granins 
are key players in the sorting and aggregation of secretory products in the trans-
Golgi network, thereby having a significant impact on vesicle biogenesis 
(Bartolomucci et al., 2011). Similarly, SRGN promotes electron-dense core for-
mation of the granules of mucosa mast cells (Braga et al., 2007). It has been ad-
vocated that the acidic GAG chains could play an active role in these processes. 
In fact, several lines of evidence implicate GAGs in proper granule formation as 
well as in the storage of basic components in both endocrine and exocrine cells 
(Abrink et al., 2004; Aroso et al., 2015; Ringvall et al., 2008).  
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  As mentioned before, CHGA is the precursor of several bioactive hor-
mone peptides such as vasostatin -1 and -2, catestatin and parastatin, with a 
broad spectrum of biological activities. Human thyroglobulin, the precursor of 
the thyroid hormones is also a CS proteoglycan (Conte et al., 2006). In Paper I 
and V, we found that other human pro-hormones (and hormone peptides) are 
carriers of CS chains, for example cholecystokinin (CCK), a hormonal regulator 
of the gastrointestinal system, and the brain natriuretic peptides (BNP), a cardiac 
hormone and a clinical marker for heart failure. Intriguingly, in both cases the 
GAG sites were located at the N-terminus of the proteins in predicted pro-
peptide regions. It is tempting to speculate that the GAG chains may be im-
portant during storage and/or processing but are absent from the functional pro-
tein after maturation (i.e. after removal of the pro-peptide regions). That would 
explain why such well-known proteins have never been observed carrying GAG 
modifications. Additionally, some of novel GAG sites are not conserved across 
mammalian species (Fig 8), which highlights the importance of carefully choos-
ing relevant experimental systems.  
Figure 8. Some of the novel GAG sites identified in this thesis are not well conserved 
between humans and other mammals (illustrated for mice and rats).  
 
As our methodology relies on proteolytically digested glycopeptides, the loca-
tion of the GAG sites in relation to the intact proteins cannot be assessed. This 
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problem becomes critical when dealing with proteins that are targeted for endog-
enous proteolytic events or that undergo alternative splicing. Nevertheless, the 
identification of GAG modifications on several proteins associated with secreto-
ry vesicles indicates that glycosylation may play an important role in this con-
text. It remains to be seen if other pro-hormones can be equally modified.  
  As it is shown in Fig 7 some other novel proteins were also found modi-
fied with GAGs. One of the general functions of the proteoglycans is to organize 
the basement membrane /ECM by interacting with collagens and laminins. Some 
collagens are known to be “de facto” proteoglycans but we also found that some 
laminins carry GAG chains as well. This finding underscores the important role 
of acidic GAG chains for tissue organization. Finally, the small-leucine rich pro-
teoglycans (SLRPs) count among the most abundant proteoglycans in the extra-
cellular space of connective tissue. In Paper I, we found that the Matrix-
Remodelling Associated protein 5 (MXRA5) also known as adlican, carries a 
GAG chain and should therefore be included among the known CS-SLPRs to-
gether with decorin, biglycan and epiphycan. 
 
Revisiting the sequence context of the GAG attachment sites 
 
Despite our findings, the proteoglycans appear to constitute a relatively small 
number of proteins, probably less than 100 genes. This limited number indicates 
that the requirements for GAG attachment are restricted and/or regulated by spe-
cific structural determinants on the acceptor core-proteins. One aspect already 
addressed in several studies is the presence of semi-consensus sequences that 
facilitate the addition of the linking xylose to the polypeptide chain. The context 
of the primary sequence appears to be critical, as GAGs are reportedly attached 
to serine residues flanked by glycine. The presence of acidic amino acids near 
the modification site also seems to be important. To date, most of these conclu-
sions have been drawn on small datasets because the number of known attach-
ment sites has been difficult to obtain. One advantage of our glycoproteomics 
approach is that the exact position of the attachment site may now be readily 
assessed.  
  We analysed the sequence of 48 experimentally determined glycosylation 
sites derived from 44 core-proteins (Fig 9). As is clearly observed from the 
WebLogo analysis, the emerging pattern largely confirmed what has been pro-
posed before, although some differences were also obvious. In addition to gly-
cine, the presence of alanine and serine residues in position +1 and -1 shows that 
they too are feasible possibilities for several endogenously glycosylated GAG 
sites. In line with that, changing the flanking glycine to the chemically equiva-
lent alanine or to serine does not disturb xylose transfer to the acceptor site of 
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bikunin (Roch et al., 2010). Based on our data, a tentative [EPA]-[GSA]-S-[GA] 
motif near acidic amino acids could be formulated although not all the sites seem 
to comply with it.  
Figure 9. WebLogo analysis of 48 experimentally determined GAG sites derived from 44 
human core proteins. 
 
  Interestingly, it has been suggested that the presence of SG repeats pro-
motes the specific assembly of HS chains over CS/DS chains. In Paper IV, we 
set up a method to analyze linkage-region glycopeptides derived from mouse 
Perlecan, a typical basement membrane proteoglycan. Perlecan is known to carry 
both HS and CS chains but how these different GAG-types relate to the glyco-
sylation sites is currently unknown. It should be mentioned that all potential 
GAG sites on Perlecan are well conserved across mammals. By digesting the 
glycans with HS- or CS-specific lyases in combination with oxonium ion analy-
sis, we determined the HS sites in Perlecan to be located on the N-terminal do-
main of the protein. The amino acid sequence ASGDGLGSGDVGSGD for the 
HS modifications agreed with the postulated requirement of SG repeats. Interest-
ingly, we also found a novel hybrid C-terminal site DWHPEGSGGN that can be 
modified with either HS or CS. The human homologous peptide was also identi-
fied in cerebrospinal fluid and urine (Paper I). Although the absence of SG-
repeats may suggest that this site is preferentially targeted for CS assembly, the 
presence of bulky aromatic residues near a GAG site (a tryptophan in this case) 
has been associated with HS rather than with CS (L. J. Zhang & Esko, 1994). 
We have also identified a hybrid site on human Collagen XVIII derived from 
human induced pluripotent stem cells (Fig 10). This attachment site looks like a 
classic CS-site but has an aromatic residue (phenylalanine) only a few amino 
acids away from the modified serine. As the data is not enough to draw any con-
clusions on this subject, it will be interesting to see if other hybrid proteoglycans 
follow the same trend.  
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Figure 10. HCD MS/MS fragmentation spectra of HS (A) and CS (B) glycopeptides de-
rived from Collagen alpha 1 (XVIII) from human iPS cells. Linkage region hexasaccha-
rides carrying HS and CS modifications are found at the same attachment site (top 
panels) but differ in their oxonium ion intensity profiles confirming the simultaneous 
presence of GlcNAc (HS) and GalNAc (CS) modifications (bottom panels). 
 
GAGs as potential allosteric factors for proteolytic processing of the proteogly-
can core-proteins 
 
Interestingly, the novel hybrid site on perlecan was found to be located only four 
amino acids away from the endogenous BMP1-cleavage site that liberates the 
LG3 domain of Endorepellin (Gonzalez et al., 2005). As discussed before, the 
LG3-domain is a proteolytic fragment of perlecan with anti-angiogenic proper-
ties. The close proximity between the cleavage- and the novel GAG- sites sug-
gests that BMP1 may physically interact with the glycan (Fig 11) which in turn 
implies that the GAG chain could serve as an allosteric element for the enzymat-
ic cleavage. This possibility becomes even more fascinating in the light of recent 
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findings showing that BMP1 is responsible for the proteolytic processing of pro-
decorin and pro-biglycan leading to the complete removal of their pro-peptide 
regions (Scott et al., 2000; von Marschall & Fisher, 2010). In both cases, the 
BMP1 cleavage sites are also located only 4-5 amino acids away from the GAG- 
attachment sites.   
 
Figure 11. Endorepellin is cleaved by BMP1 only three amino acids away from the C-
terminal hybrid site (A) releasing the LG3 domain, one of the laminin-G-domains (LamG) 
of perlecan. In B, the crystal structure of the proteolytic domain of BMP1 is depicted with 
a modelled peptide inside the catalytic cleft corresponding to the sequence around the 
endorepellin cleavage site. The GAG-site serine is coloured in red. The closeness between 
the proteolytic site and the GAG site suggests that the GAG-chain may physically interact 
with the protease and modulate the cleavage possibly by binding to the rim of positively 
charged amino acids of the BMP1 surface (positive=blue, neutral=white, negative=red). 
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To the best of our knowledge, an allosteric role for the proteoglycan GAG chains 
during proteolytic processing of their own core-proteins has never been suggest-
ed before. However, the fact that some proteoglycans are processed in complex 
ways in both health and disease, and that some proteolytic events take place near 
glycosylation sites should encourage an exploration of this possibility through 
experimental means in relevant systems. The methodology described in Paper IV 
could help in addressing this fundamental question.  
4.3 Targeting the glycan  
Revisiting the structure of the proteoglycan linkage region 
 
The assembly of the proteoglycan linking tetrasaccharide constitutes an im-
portant checkpoint for CS and HS biosynthetic regulation. Several glycan substi-
tutions have been reported so far, some of them having a regulatory function. 
The analysis of glycopeptides as conducted in Paper I allowed for characteriza-
tion of the glycan structure of the linkage region in addition to pinpointing the 
GAG attachment sites. In Paper II, we conducted a detailed characterization of 
bikunin CS glycopeptides across different human body fluids. Bikunin is the 
light chain of the inter-alpha-trypsin inhibitor (IαI) protein family, which is high-
ly abundant in body fluids. The IαI complex is composed of a unique macromo-
lecular arrangement of several heavy chains (H1, H2 and H3) proteins cross-
linked to the CS-GAG chain of bikunin through Asp to GalNAc ester bonds 
(Salier et al., 1996). The free form of bikunin is known as the urinary trypsin 
inhibitor (UTI). Bikunin is probably one of the best-studied vertebrate proteo-
glycans and its GAG chain is apparently simple. It carries a single low-sulfated 
CS chain attached at Ser-10 with a uniform GlcA stereochemistry. The linkage 
region has been structurally addressed in previous studies concluding a uniform 
4-O- sulfation of the second Gal (Chi et al., 2008; Yamada et al., 1995). The 
heavy chains are crosslinked towards the non-reducing end of the CS chain but 
their exact arrangement has not been completely established (Enghild et al., 
1989).  
  With this information in mind, it was very surprising to find in Paper II 
that the linkage region of bikunin was unprecedentedly heterogeneous. In addi-
tion to Gal sulfation, we were also able to identify a subpopulation carrying xy-
lose phosphorylation, specifically in urinary samples. Similarly, several other 
phosphorylated CSPGs were also detected in urine and CSF as shown in Paper I. 
In general, xylose phosphorylation in bikunin and in the other native proteogly-
cans occurred at substoichiometrical levels. Unfortunately, as partial glycan de-
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polymerization was conducted before MS analysis it was not possible to assess if 
the phosphorylated GAGs differed in any respect from their non-sulfated coun-
terparts. However, during enrichment, the glycopeptides carrying intact GAG 
chains were separated by SAX chromatography and their elution profiles thus 
correlate with their length and/or sulfation degree. We found that GAGs with 
unmodified or phosphorylated linkage regions were mostly recovered in the low-
salt elution fractions indicating shorter or less sulfated chains. Also in line with 
previous studies, we identified some degree of xylose phosphorylation in the 
linkage regions of HS proteoglycans as reported in Paper IV. 
  Beside the well-studied xylose phosphorylation, we show in Paper II that 
the innermost Gal of bikunin can also be decorated with a novel NeuAc modifi-
cation. A NeuAcα2,3 capping of the Gal has been described before in CSPG 
linkage regions derived from FAM20B knocked cells and in xyloside-primed 
GAGs from skin fibroblasts (Takagaki et al., 1996; Wen et al., 2014). However, 
given that the NeuAc modifications on bikunin was observed on structures ex-
tended with at least one disaccharide beyond the linking tetrasaccharide, the at-
tachment of the NeuAc moiety should be different from those previously 
reported (and most likely a 2,6-linkage). Additionally, novel fucose modifica-
tions were also detected in urinary bikunin (Paper II) as well as in other native 
human CSPGs (Paper III and V). Based on the MS data, the fucose moiety was 
invariably attached to the linking xylose. As discussed in the method section, the 
glycan linkage position is not possible to obtain from a glycoproteomics experi-
ment but there is an intriguing possibility that the fucosylation may compete 
with the C-2 phosphorylation of xylose. The biosynthesis of fucosyl-branched 
CS-structures has been demonstrated in some echinoderms such as sea cucum-
bers but not in higher organisms (Myron et al., 2014). Taken together, the find-
ings presented in this thesis indicate that the structure of the CS linkage region of 
bikunin is highly heterogeneous, contrary to previous studies. We also reported 
novel NeuAc and Fuc modifications of the linkage region of bikunin and of other 
human CSPGs, which points to the existence of yet unknown glycosyltransferas-
es involved in the biosynthesis of CS chains. The extent and biological impor-
tance of these novel modifications remains to be determined.  
 
Solving the IαI structural puzzle 
 
The CS chain of bikunin is also unique in the sense that it is often cross-linked to 
several heavy chain proteins to give rise to the IαI complexes (Salier et al., 
1996). The IαI complex is composed of bikunin cross-linked through its CS 
chain to either H1 or H2 or both. 
58   4 .  RES U LTS  AND  DI S CU SSI ON
 
  The combination of bikunin and H3 is known as the pre-α-trypsin inhibi-
tor. By digesting these molecules with a cocktail of CS-specific lyases (Chond 
ABC), we obtained both bikunin linkage region glycopeptides and C-terminal 
glycopeptides derived from the crosslinked regions of H1 and H2 from human 
CSF and plasma samples. In most cases, both heavy chains were simultaneously 
attached to the same CS-stretch and near each other. Additionally, we could also 
identify H1 cross-linking glycopeptides at the very non-reducing end of the CS 
chain. A summary of all our findings for the linkage and cross-linkage region of 
native bikunin are presented in Fig 12.   
  
Figure 12. Summary of all the findings presented in this thesis about the structure of the 
inter-alpha-trypsin inhibitor complex derived from human plasma and cerebrospinal 
fluid. The light chain bikunin displays a broad heterogeneity of its linkage region. The 
heavy chains 1 and 2 are located towards the non-reducing end in close vicinity to each 
other.  
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4.4 Targeting biology 
 
Identification of specific remodelling of the CS-glycosylation of iPS cells using a 
unique malaria protein probe 
 
Proteoglycans are deeply involved in key developmental processes and as men-
tioned before, a specific instructional role for HS during vertebrate development 
has been suggested (Kraushaar et al., 2013; Poulain & Yost, 2015). Equally, HS 
GAG chains have been implicated in the regulation of stem cell behaviour and 
differentiation (Mikami & Kitagawa, 2016; Tamm et al., 2012). The role of CS 
during these processes has been less well explored. Recent findings indicate that 
deregulation of normal stem cell functions is tightly linked to tumorigenesis and 
malignant cellular transformation (Shackleton, 2010). As acidic GAG polysac-
charides are important for shaping both the stem cell niches and the tumour mi-
croenvironments we hypothesized that specific proteoglycan signatures might be 
shared between particular stem cell populations and tumour cells.  
  In Paper V, we used a unique recombinant protein probe (rVAR2) derived 
from the malaria VAR2CSA protein that specifically interacts with distinct CSA 
populations in the placenta as well as in a broad array of human tumour cells. 
We demonstrated that rVAR2 affinity purification in conjunction with a glyco-
proteomics workflow is a feasible way of obtaining site-specific glycan infor-
mation on the selected CSA-populations targeted by the probe. In sharp contrast 
to the placental setting where rVAR2-reactive CS-chains are specifically assem-
bled on Syndecan-1, we found that a heterogeneous group of core proteins are 
the targets for CSA-attachment in tumour cells of different origins. As the pla-
centa-type CSA modifications in cancer cells are involved in tumour motility 
(Clausen et al., 2016), it is possible that an increase in GAG presentation by mo-
bilizing several core-proteins directly mediates or facilitates the acquirement of a 
more aggressive and invasive tumour phenotype. In line with our initial hypothe-
sis, we also observed that rVAR2-reactive CSPGs are present in iPS cells. Fur-
thermore, the absence of reactivity in the parental somatic cell line indicated that 
this expression was induced by cellular reprogramming and might therefore be 
under stage-specific regulation. Similar to the cancer setting, the assembly of the 
placenta-type CSA in iPS cells occurred on multiple core proteins but their spe-
cific functional roles remain to be determined.  
  The occurrence of dramatic changes in glycosylation during cellular tran-
sitions has been reported. These changes are not only restricted to proteoglycans 
but also encompass other glycoconjugates such as N- and O-glycoproteins and 
glycolipids. For example, the cell surface glycosphingolipids SSEA-3 and -4 are  
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Figure 13. Lectin staining of a human chondrocyte cell line and iPS cells derived there-
from showing distinct differences in glycophenotypes. WGA: Wheat germ agglutinin, 
PNA: Peanut agglutinin, UEA-1: Ulex europaeus agglutinin 1, and DBA: Dolichos biflo-
rus agglutinin. 
 
stage-specific carbohydrate antigens that are useful for the identification of cell 
populations with stem cell traits (A. L. Yu et al., 2016). Pluripotent stem cells 
are also characterized by an increase in high mannose N-glycan structures com-
pared to fully differentiated cells, whereas complex type N-glycans are much 
more abundant in differentiated cells (Fujitani et al., 2013; Furukawa et al., 
2016). In some cases, this glycan remodelling has been shown to follow differ-
ential transcriptional changes in the glycosylation machinery (Nairn et al., 2012). 
By using a panel of carbohydrate-binding lectins to stain chondrocyte-derived 
iPS cells and their parental articular chondrocytes, we have also confirmed that 
major changes in the expression of alpha1,2-fucose (as recognized by UEA-1) 
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and the T-antigen Galβ1,3GalNAcα1 -Ser/Thr (as recognized by PNA) are also 
associated with pluripotent cellular states (Fig 13). The remodelling of the cellu-
lar glycosylation landscape during cellular transitions, and particularly during 
differentiation, is the result of the complex interplay between dynamic signalling 
and transcriptional waves. If these resulting “glycowaves” are a mere reflection 
of the transcriptional state of the cell or if they are contributing factors that ac-
tively facilitate overcoming kinetic barriers during cellular transitions, is an im-
portant question that remains to be elucidated.   
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5. Conclusions  
The general aim of this thesis was to develop comprehensive and high-
throughput methods for the structural characterization of native CS/DS- and HS-
proteoglycans from complex biological samples. Given the chemical complexity 
of these molecules not all structural aspects could be simultaneously addressed. 
Since the discovery of the proteoglycans, a broad array of different techniques 
has been developed to obtain the average structure of GAG chains as wells as to 
get insights into their sulfation patterns. These advances have facilitated our un-
derstanding of the biological importance of the proteoglycans and their impact in 
human health and disease. However, the number of known proteoglycans ap-
pears to be limited and the GAG attachment sites on the core proteins have been 
difficult to access. In this thesis, we have focused on these two aspects by devel-
oping new glycoproteomics concepts and tools. 
  Taken together, our results indicate that GAG-attachment occurs on a 
broader spectrum of core proteins than was previously known and expected. We 
found that several human pro-hormones are de facto CS-proteoglycans, suggest-
ing a general function for acidic GAGs in the storage and/or processing of some 
cargo proteins within secretory vesicles. By analysing multiple, experimentally 
determined GAG sites, we also show that the human xylosyltransferases act on 
semi-consensus motifs although these sequences are not as well defined as pre-
viously assumed. Additionally, some specific GAG sites display a hybrid nature, 
allowing for the simultaneous presentations of different GAGs types at the same 
amino acid position. 
   We also discovered that the proteoglycan linkage region is the target for 
unexpected glycan modifications such as sialylation and fucosylation. This find-
ing indicates that there are other glycosyltransferases involved in the biosynthe-
sis of these complex glycans, which might have implications for their 
biosynthetic regulation. Finally, we demonstrated that placental-type CS-chains 
are expressed in iPS cells in a stage specific manner. By using the methods de-
scribed in this thesis, it was also possible to address their GAG attachment site-
specificity in a high throughput fashion. It is our view that these glycoprote-
omics methods and techniques are to be considered complementary to more es-
tablished glycan-oriented approaches. Together, they will help the biochemical 
community to understand all the intricate structural complexity of the proteogly-
cans and hopefully, facilitate the full exploration of the role of these glyconju-
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gates in basic biology and stem cell research as well as in clinical settings, serv-
ing as novel biomarkers or as relevant therapeutic targets. 
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6. Future Perspectives 
The way natural sciences have evolved in western tradition has shaped our idea 
of science as an experimental method, rather than as a well-defined intellectual 
product. “The scientific method”, this iterative procedure of collecting and 
measuring observations about nature to test and modify hypothesis, has also all 
the ingredients of a truly intellectual process. Therefore, it is very common that 
sound scientific work revolves around finding new answers to old problems as 
well as raising new questions from new findings.   
  Given our finding that some pro-hormones are carriers of GAG modifica-
tion, it would be interesting to assess if other pro-hormones are also decorated 
with GAG chains. The assessment of the extent and biological function of such 
modifications in human endocrine cells can give new mechanistic insights into 
multiple diseases, ranging from diabetes to endocrine tumours. GAG chains are 
highly acidic and may aid in the storage of positively charged cargo molecules 
within secretory vesicles. The importance of such glycan modification for the 
specific function of the granins during vesicle biogenesis has so far not been 
addressed, but it is expected to play an important role. The methods developed 
during this thesis in conjunction with genetic deconstruction of the GAG biosyn-
thesis may help to address these fundamental questions in relevant cell systems. 
  The presence of oncofetal CS-modifications in iPS cells also needs further 
clarification. To determine if this GAG expression is a general feature of plu-
ripotent stem cells, a broader number of iPS and ES cells need to be tested. A 
closer evaluation of the expression of oncofetal CS in relation to pluripotency 
and differentiation markers is also required as well as a deep mechanistic under-
standing of their function for self-renewal and lineage specification. There is an 
appealing possibility that this GAG expression may constitute a molecular win-
dow to deliver specific signals to the stem cells to generate homogenous clinical-
grade stem cell cultures for safe clinical purposes. Additionally, this finding 
should be put in relation to the broad expression of these CS-chains in multiple 
human tumours. How exactly deregulation of stem cell functions is connected to 
carcinogenesis is currently not completely understood. However, new insights 
may come from the study of how changes in the glycosylation affect the kinetics 
of cellular transitions.  
  There are still some basic questions regarding the structural diversity and 
regulation of mammalian proteoglycans that need further exploration. Our ob-
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servation of novel glycan modifications at the proteoglycan linkage region clear-
ly revealed the possible existence of yet unknown glycosyltransferases involved 
in GAG biosynthesis. Their identities, enzymatic activities and potential roles in 
the regulation of GAG assembly should also be addressed in future studies. Fi-
nally, the prospect of achieving a global site-specific analysis of full-length pro-
teoglycans in complex samples is a long-term goal that still remains a challenge. 
It is also possible that thematic variations of the methodologies presented in this 
thesis may help to address structural studies of other classes of proteoglycans 
e.g. the keratan sulfate and glycosylphosphatidylinositol anchored proteogly-
cans. However, high throughput exploration of CS/DS- and HS- proteoglycans 
in biological samples can already, as described here, be accurately performed on 
generally available, sensitive and robust analytical platforms.  
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